nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—CYP1A2—Anagrelide—hematologic cancer	0.0362	0.0596	CbGbCtD
Thioridazine—CYP2E1—Thalidomide—hematologic cancer	0.0231	0.0381	CbGbCtD
Thioridazine—CYP2C9—Bexarotene—hematologic cancer	0.0226	0.0372	CbGbCtD
Thioridazine—CYP2E1—Dacarbazine—hematologic cancer	0.0199	0.0328	CbGbCtD
Thioridazine—CYP2C8—Bortezomib—hematologic cancer	0.0198	0.0327	CbGbCtD
Thioridazine—CYP2D6—Lomustine—hematologic cancer	0.0192	0.0316	CbGbCtD
Thioridazine—CYP1A2—Carmustine—hematologic cancer	0.019	0.0313	CbGbCtD
Thioridazine—CYP2C9—Idarubicin—hematologic cancer	0.0187	0.0308	CbGbCtD
Thioridazine—CYP2D6—Idarubicin—hematologic cancer	0.0171	0.0282	CbGbCtD
Thioridazine—CYP2C19—Bortezomib—hematologic cancer	0.0167	0.0274	CbGbCtD
Thioridazine—CYP1A2—Methoxsalen—hematologic cancer	0.0162	0.0266	CbGbCtD
Thioridazine—CYP2E1—Mitoxantrone—hematologic cancer	0.0154	0.0254	CbGbCtD
Thioridazine—CYP1A2—Bortezomib—hematologic cancer	0.0154	0.0253	CbGbCtD
Thioridazine—CYP2C8—Ifosfamide—hematologic cancer	0.0152	0.0251	CbGbCtD
Thioridazine—CYP1A2—Daunorubicin—hematologic cancer	0.0147	0.0242	CbGbCtD
Thioridazine—CYP2D6—Hydroxyurea—hematologic cancer	0.0146	0.024	CbGbCtD
Thioridazine—CYP2C19—Thalidomide—hematologic cancer	0.0145	0.0239	CbGbCtD
Thioridazine—CYP1A2—Alitretinoin—hematologic cancer	0.0144	0.0237	CbGbCtD
Thioridazine—CYP2C9—Bortezomib—hematologic cancer	0.0138	0.0228	CbGbCtD
Thioridazine—CYP2C19—Teniposide—hematologic cancer	0.0138	0.0228	CbGbCtD
Thioridazine—CYP1A2—Thalidomide—hematologic cancer	0.0134	0.022	CbGbCtD
Thioridazine—CYP2C8—Nilotinib—hematologic cancer	0.0132	0.0218	CbGbCtD
Thioridazine—CYP2C19—Ifosfamide—hematologic cancer	0.0128	0.021	CbGbCtD
Thioridazine—CYP2D6—Bortezomib—hematologic cancer	0.0127	0.0208	CbGbCtD
Thioridazine—CYP2C19—Imatinib—hematologic cancer	0.0122	0.0201	CbGbCtD
Thioridazine—CYP2C9—Thalidomide—hematologic cancer	0.0121	0.0199	CbGbCtD
Thioridazine—CYP1A2—Dacarbazine—hematologic cancer	0.0115	0.019	CbGbCtD
Thioridazine—CYP2C9—Teniposide—hematologic cancer	0.0115	0.0189	CbGbCtD
Thioridazine—CYP1A2—Imatinib—hematologic cancer	0.0113	0.0185	CbGbCtD
Thioridazine—CYP2C9—Ifosfamide—hematologic cancer	0.0106	0.0175	CbGbCtD
Thioridazine—CYP2C9—Imatinib—hematologic cancer	0.0101	0.0167	CbGbCtD
Thioridazine—CYP2E1—Etoposide—hematologic cancer	0.00974	0.016	CbGbCtD
Thioridazine—CYP2D6—Imatinib—hematologic cancer	0.00927	0.0153	CbGbCtD
Thioridazine—CYP2C9—Nilotinib—hematologic cancer	0.00922	0.0152	CbGbCtD
Thioridazine—CYP1A2—Dasatinib—hematologic cancer	0.00904	0.0149	CbGbCtD
Thioridazine—CYP2D6—Nilotinib—hematologic cancer	0.00843	0.0139	CbGbCtD
Thioridazine—CYP2D6—Vinorelbine—hematologic cancer	0.00836	0.0138	CbGbCtD
Thioridazine—CYP2C19—Prednisone—hematologic cancer	0.00804	0.0132	CbGbCtD
Thioridazine—CYP2E1—Dexamethasone—hematologic cancer	0.00801	0.0132	CbGbCtD
Thioridazine—CYP2C8—Etoposide—hematologic cancer	0.00728	0.012	CbGbCtD
Thioridazine—CYP2C8—Dexamethasone—hematologic cancer	0.00598	0.00985	CbGbCtD
Thioridazine—CYP1A2—Etoposide—hematologic cancer	0.00563	0.00927	CbGbCtD
Thioridazine—CYP2C9—Cisplatin—hematologic cancer	0.00516	0.0085	CbGbCtD
Thioridazine—CYP2D6—Vinblastine—hematologic cancer	0.00515	0.00848	CbGbCtD
Thioridazine—CYP2C19—Dexamethasone—hematologic cancer	0.00502	0.00826	CbGbCtD
Thioridazine—CYP2C9—Dexamethasone—hematologic cancer	0.00417	0.00687	CbGbCtD
Thioridazine—CYP2D6—Dexamethasone—hematologic cancer	0.00381	0.00628	CbGbCtD
Thioridazine—CYP2D6—Doxorubicin—hematologic cancer	0.00316	0.00521	CbGbCtD
Thioridazine—HTR1A—hematopoietic system—hematologic cancer	0.000766	0.0386	CbGeAlD
Thioridazine—HTR7—hematopoietic system—hematologic cancer	0.000732	0.0369	CbGeAlD
Thioridazine—CYP2C19—hematopoietic system—hematologic cancer	0.000715	0.036	CbGeAlD
Thioridazine—ADRA1A—hematopoietic system—hematologic cancer	0.000706	0.0356	CbGeAlD
Thioridazine—KCNH2—hematopoietic system—hematologic cancer	0.000682	0.0344	CbGeAlD
Thioridazine—CYP2C8—hematopoietic system—hematologic cancer	0.000624	0.0314	CbGeAlD
Thioridazine—CYP1A2—hematopoietic system—hematologic cancer	0.000584	0.0294	CbGeAlD
Thioridazine—HTR7—gonad—hematologic cancer	0.000557	0.028	CbGeAlD
Thioridazine—CYP2C9—hematopoietic system—hematologic cancer	0.000554	0.0279	CbGeAlD
Thioridazine—HRH1—hematopoietic system—hematologic cancer	0.000547	0.0275	CbGeAlD
Thioridazine—ADRA2A—hematopoietic system—hematologic cancer	0.000537	0.0271	CbGeAlD
Thioridazine—CYP2E1—hematopoietic system—hematologic cancer	0.000525	0.0265	CbGeAlD
Thioridazine—HTR7—blood—hematologic cancer	0.000485	0.0244	CbGeAlD
Thioridazine—CYP2C19—blood—hematologic cancer	0.000474	0.0239	CbGeAlD
Thioridazine—ADRA1A—blood—hematologic cancer	0.000468	0.0236	CbGeAlD
Thioridazine—HTR2A—hematopoietic system—hematologic cancer	0.000457	0.023	CbGeAlD
Thioridazine—KCNH2—blood—hematologic cancer	0.000452	0.0228	CbGeAlD
Thioridazine—KCNH2—bone marrow—hematologic cancer	0.000437	0.022	CbGeAlD
Thioridazine—HTR7—lung—hematologic cancer	0.000425	0.0214	CbGeAlD
Thioridazine—CYP2D6—hematopoietic system—hematologic cancer	0.000416	0.021	CbGeAlD
Thioridazine—CYP2C8—blood—hematologic cancer	0.000413	0.0208	CbGeAlD
Thioridazine—ADRA2A—gonad—hematologic cancer	0.000408	0.0206	CbGeAlD
Thioridazine—DRD2—lung—hematologic cancer	0.000402	0.0203	CbGeAlD
Thioridazine—HTR7—testis—hematologic cancer	0.000401	0.0202	CbGeAlD
Thioridazine—CYP1A2—blood—hematologic cancer	0.000387	0.0195	CbGeAlD
Thioridazine—DRD2—testis—hematologic cancer	0.000379	0.0191	CbGeAlD
Thioridazine—KCNH2—testis—hematologic cancer	0.000374	0.0188	CbGeAlD
Thioridazine—CYP2C9—blood—hematologic cancer	0.000367	0.0185	CbGeAlD
Thioridazine—ADRA2A—blood—hematologic cancer	0.000356	0.0179	CbGeAlD
Thioridazine—CYP2E1—blood—hematologic cancer	0.000348	0.0175	CbGeAlD
Thioridazine—HTR2A—gonad—hematologic cancer	0.000347	0.0175	CbGeAlD
Thioridazine—CYP2C8—testis—hematologic cancer	0.000342	0.0172	CbGeAlD
Thioridazine—CYP1A2—lung—hematologic cancer	0.000339	0.0171	CbGeAlD
Thioridazine—HRH1—lung—hematologic cancer	0.000317	0.016	CbGeAlD
Thioridazine—ADRA2A—lung—hematologic cancer	0.000312	0.0157	CbGeAlD
Thioridazine—CYP2E1—lung—hematologic cancer	0.000305	0.0154	CbGeAlD
Thioridazine—HTR2A—blood—hematologic cancer	0.000302	0.0152	CbGeAlD
Thioridazine—HRH1—testis—hematologic cancer	0.0003	0.0151	CbGeAlD
Thioridazine—ADRA2A—testis—hematologic cancer	0.000294	0.0148	CbGeAlD
Thioridazine—CYP2E1—testis—hematologic cancer	0.000288	0.0145	CbGeAlD
Thioridazine—CYP2D6—blood—hematologic cancer	0.000276	0.0139	CbGeAlD
Thioridazine—KCNH2—lymph node—hematologic cancer	0.000271	0.0136	CbGeAlD
Thioridazine—HTR2A—lung—hematologic cancer	0.000265	0.0134	CbGeAlD
Thioridazine—HTR2A—testis—hematologic cancer	0.00025	0.0126	CbGeAlD
Thioridazine—Acepromazine—SLC22A1—hematologic cancer	0.000237	0.117	CrCbGaD
Thioridazine—Thioproperazine—SLC22A1—hematologic cancer	0.000232	0.114	CrCbGaD
Thioridazine—Pipotiazine—SLC22A1—hematologic cancer	0.000228	0.112	CrCbGaD
Thioridazine—Thiothixene—SLC22A1—hematologic cancer	0.000228	0.112	CrCbGaD
Thioridazine—CYP2D6—testis—hematologic cancer	0.000228	0.0115	CbGeAlD
Thioridazine—HRH1—lymph node—hematologic cancer	0.000217	0.0109	CbGeAlD
Thioridazine—ADRA2A—lymph node—hematologic cancer	0.000213	0.0107	CbGeAlD
Thioridazine—Clomipramine—GSTP1—hematologic cancer	0.000195	0.0961	CrCbGaD
Thioridazine—Chlorpromazine—SLC22A1—hematologic cancer	0.000124	0.061	CrCbGaD
Thioridazine—Eletriptan—ABCB1—hematologic cancer	9.85e-05	0.0485	CrCbGaD
Thioridazine—Drowsiness—Methotrexate—hematologic cancer	8.06e-05	0.000318	CcSEcCtD
Thioridazine—Pancytopenia—Epirubicin—hematologic cancer	8.03e-05	0.000317	CcSEcCtD
Thioridazine—Headache—Bortezomib—hematologic cancer	8.03e-05	0.000317	CcSEcCtD
Thioridazine—Hypotension—Etoposide—hematologic cancer	8.02e-05	0.000316	CcSEcCtD
Thioridazine—Rash—Bleomycin—hematologic cancer	8.02e-05	0.000316	CcSEcCtD
Thioridazine—Dermatitis—Bleomycin—hematologic cancer	8.01e-05	0.000316	CcSEcCtD
Thioridazine—Hypersensitivity—Ifosfamide—hematologic cancer	8.01e-05	0.000316	CcSEcCtD
Thioridazine—Vomiting—Vinorelbine—hematologic cancer	7.95e-05	0.000314	CcSEcCtD
Thioridazine—Body temperature increased—Gemcitabine—hematologic cancer	7.95e-05	0.000313	CcSEcCtD
Thioridazine—Angioedema—Betamethasone—hematologic cancer	7.91e-05	0.000312	CcSEcCtD
Thioridazine—Angioedema—Dexamethasone—hematologic cancer	7.91e-05	0.000312	CcSEcCtD
Thioridazine—Diarrhoea—Thalidomide—hematologic cancer	7.91e-05	0.000312	CcSEcCtD
Thioridazine—Rash—Vinorelbine—hematologic cancer	7.89e-05	0.000311	CcSEcCtD
Thioridazine—Dermatitis—Vinorelbine—hematologic cancer	7.88e-05	0.000311	CcSEcCtD
Thioridazine—Headache—Vinorelbine—hematologic cancer	7.84e-05	0.000309	CcSEcCtD
Thioridazine—Asthma—Doxorubicin—hematologic cancer	7.83e-05	0.000309	CcSEcCtD
Thioridazine—Hypersensitivity—Vincristine—hematologic cancer	7.81e-05	0.000308	CcSEcCtD
Thioridazine—Oedema—Triamcinolone—hematologic cancer	7.78e-05	0.000307	CcSEcCtD
Thioridazine—Eosinophilia—Doxorubicin—hematologic cancer	7.75e-05	0.000306	CcSEcCtD
Thioridazine—Arrhythmia—Prednisone—hematologic cancer	7.73e-05	0.000305	CcSEcCtD
Thioridazine—Photosensitivity reaction—Epirubicin—hematologic cancer	7.72e-05	0.000304	CcSEcCtD
Thioridazine—Feeling abnormal—Cisplatin—hematologic cancer	7.72e-05	0.000304	CcSEcCtD
Thioridazine—Weight increased—Epirubicin—hematologic cancer	7.7e-05	0.000304	CcSEcCtD
Thioridazine—Somnolence—Etoposide—hematologic cancer	7.63e-05	0.000301	CcSEcCtD
Thioridazine—Nausea—Bortezomib—hematologic cancer	7.61e-05	0.0003	CcSEcCtD
Thioridazine—Hypersensitivity—Mitoxantrone—hematologic cancer	7.6e-05	0.0003	CcSEcCtD
Thioridazine—Hypersensitivity—Irinotecan—hematologic cancer	7.6e-05	0.0003	CcSEcCtD
Thioridazine—Tachycardia—Triamcinolone—hematologic cancer	7.6e-05	0.0003	CcSEcCtD
Thioridazine—Vomiting—Thiotepa—hematologic cancer	7.6e-05	0.0003	CcSEcCtD
Thioridazine—Diarrhoea—Carmustine—hematologic cancer	7.59e-05	0.000299	CcSEcCtD
Thioridazine—Mental disorder—Prednisone—hematologic cancer	7.58e-05	0.000299	CcSEcCtD
Thioridazine—Nausea—Bleomycin—hematologic cancer	7.55e-05	0.000298	CcSEcCtD
Thioridazine—Drowsiness—Epirubicin—hematologic cancer	7.54e-05	0.000297	CcSEcCtD
Thioridazine—Erythema—Prednisone—hematologic cancer	7.54e-05	0.000297	CcSEcCtD
Thioridazine—Rash—Thiotepa—hematologic cancer	7.53e-05	0.000297	CcSEcCtD
Thioridazine—Dermatitis—Thiotepa—hematologic cancer	7.53e-05	0.000297	CcSEcCtD
Thioridazine—Hyperhidrosis—Triamcinolone—hematologic cancer	7.53e-05	0.000297	CcSEcCtD
Thioridazine—Diarrhoea—Alitretinoin—hematologic cancer	7.52e-05	0.000297	CcSEcCtD
Thioridazine—Agranulocytosis—Methotrexate—hematologic cancer	7.52e-05	0.000297	CcSEcCtD
Thioridazine—Headache—Thiotepa—hematologic cancer	7.48e-05	0.000295	CcSEcCtD
Thioridazine—Triflupromazine—ABCB1—hematologic cancer	7.46e-05	0.0367	CrCbGaD
Thioridazine—Decreased appetite—Etoposide—hematologic cancer	7.46e-05	0.000294	CcSEcCtD
Thioridazine—Diarrhoea—Ifosfamide—hematologic cancer	7.43e-05	0.000293	CcSEcCtD
Thioridazine—Pancytopenia—Doxorubicin—hematologic cancer	7.43e-05	0.000293	CcSEcCtD
Thioridazine—Nausea—Vinorelbine—hematologic cancer	7.43e-05	0.000293	CcSEcCtD
Thioridazine—Body temperature increased—Cisplatin—hematologic cancer	7.41e-05	0.000292	CcSEcCtD
Thioridazine—Jaundice—Epirubicin—hematologic cancer	7.35e-05	0.00029	CcSEcCtD
Thioridazine—Vomiting—Thalidomide—hematologic cancer	7.35e-05	0.00029	CcSEcCtD
Thioridazine—Constipation—Etoposide—hematologic cancer	7.34e-05	0.000289	CcSEcCtD
Thioridazine—Rash—Thalidomide—hematologic cancer	7.29e-05	0.000287	CcSEcCtD
Thioridazine—Dermatitis—Thalidomide—hematologic cancer	7.28e-05	0.000287	CcSEcCtD
Thioridazine—Diarrhoea—Vincristine—hematologic cancer	7.25e-05	0.000286	CcSEcCtD
Thioridazine—Headache—Thalidomide—hematologic cancer	7.24e-05	0.000285	CcSEcCtD
Thioridazine—Acepromazine—ALB—hematologic cancer	7.24e-05	0.0356	CrCbGaD
Thioridazine—Photosensitivity reaction—Doxorubicin—hematologic cancer	7.14e-05	0.000282	CcSEcCtD
Thioridazine—Weight increased—Doxorubicin—hematologic cancer	7.12e-05	0.000281	CcSEcCtD
Thioridazine—Vision blurred—Prednisone—hematologic cancer	7.1e-05	0.00028	CcSEcCtD
Thioridazine—Nausea—Thiotepa—hematologic cancer	7.1e-05	0.00028	CcSEcCtD
Thioridazine—Feeling abnormal—Etoposide—hematologic cancer	7.07e-05	0.000279	CcSEcCtD
Thioridazine—Thioproperazine—ALB—hematologic cancer	7.07e-05	0.0348	CrCbGaD
Thioridazine—Oedema—Dexamethasone—hematologic cancer	7.06e-05	0.000279	CcSEcCtD
Thioridazine—Oedema—Betamethasone—hematologic cancer	7.06e-05	0.000279	CcSEcCtD
Thioridazine—Diarrhoea—Mitoxantrone—hematologic cancer	7.06e-05	0.000278	CcSEcCtD
Thioridazine—Diarrhoea—Irinotecan—hematologic cancer	7.06e-05	0.000278	CcSEcCtD
Thioridazine—Vomiting—Carmustine—hematologic cancer	7.06e-05	0.000278	CcSEcCtD
Thioridazine—Agranulocytosis—Epirubicin—hematologic cancer	7.04e-05	0.000278	CcSEcCtD
Thioridazine—Rash—Carmustine—hematologic cancer	7e-05	0.000276	CcSEcCtD
Thioridazine—Dermatitis—Carmustine—hematologic cancer	6.99e-05	0.000276	CcSEcCtD
Thioridazine—Vomiting—Alitretinoin—hematologic cancer	6.99e-05	0.000276	CcSEcCtD
Thioridazine—Drowsiness—Doxorubicin—hematologic cancer	6.98e-05	0.000275	CcSEcCtD
Thioridazine—Feeling abnormal—Prednisolone—hematologic cancer	6.98e-05	0.000275	CcSEcCtD
Thioridazine—Anaemia—Prednisone—hematologic cancer	6.97e-05	0.000275	CcSEcCtD
Thioridazine—Pipotiazine—ALB—hematologic cancer	6.96e-05	0.0343	CrCbGaD
Thioridazine—Thiothixene—ALB—hematologic cancer	6.96e-05	0.0343	CrCbGaD
Thioridazine—Headache—Carmustine—hematologic cancer	6.95e-05	0.000274	CcSEcCtD
Thioridazine—Rash—Alitretinoin—hematologic cancer	6.93e-05	0.000273	CcSEcCtD
Thioridazine—Agitation—Prednisone—hematologic cancer	6.93e-05	0.000273	CcSEcCtD
Thioridazine—Dermatitis—Alitretinoin—hematologic cancer	6.93e-05	0.000273	CcSEcCtD
Thioridazine—Thrombocytopenia—Dexamethasone—hematologic cancer	6.92e-05	0.000273	CcSEcCtD
Thioridazine—Thrombocytopenia—Betamethasone—hematologic cancer	6.92e-05	0.000273	CcSEcCtD
Thioridazine—Vomiting—Ifosfamide—hematologic cancer	6.91e-05	0.000272	CcSEcCtD
Thioridazine—Hypersensitivity—Cisplatin—hematologic cancer	6.9e-05	0.000272	CcSEcCtD
Thioridazine—Tachycardia—Dexamethasone—hematologic cancer	6.89e-05	0.000272	CcSEcCtD
Thioridazine—Tachycardia—Betamethasone—hematologic cancer	6.89e-05	0.000272	CcSEcCtD
Thioridazine—Headache—Alitretinoin—hematologic cancer	6.89e-05	0.000272	CcSEcCtD
Thioridazine—Angioedema—Prednisone—hematologic cancer	6.89e-05	0.000272	CcSEcCtD
Thioridazine—Diarrhoea—Gemcitabine—hematologic cancer	6.88e-05	0.000271	CcSEcCtD
Thioridazine—Nausea—Thalidomide—hematologic cancer	6.86e-05	0.000271	CcSEcCtD
Thioridazine—Rash—Ifosfamide—hematologic cancer	6.85e-05	0.00027	CcSEcCtD
Thioridazine—Dermatitis—Ifosfamide—hematologic cancer	6.84e-05	0.00027	CcSEcCtD
Thioridazine—Hyperhidrosis—Betamethasone—hematologic cancer	6.83e-05	0.000269	CcSEcCtD
Thioridazine—Hyperhidrosis—Dexamethasone—hematologic cancer	6.83e-05	0.000269	CcSEcCtD
Thioridazine—Jaundice—Doxorubicin—hematologic cancer	6.8e-05	0.000268	CcSEcCtD
Thioridazine—Body temperature increased—Etoposide—hematologic cancer	6.78e-05	0.000268	CcSEcCtD
Thioridazine—Vomiting—Vincristine—hematologic cancer	6.74e-05	0.000266	CcSEcCtD
Thioridazine—Anorexia—Betamethasone—hematologic cancer	6.73e-05	0.000265	CcSEcCtD
Thioridazine—Anorexia—Dexamethasone—hematologic cancer	6.73e-05	0.000265	CcSEcCtD
Thioridazine—Rash—Vincristine—hematologic cancer	6.68e-05	0.000263	CcSEcCtD
Thioridazine—Dermatitis—Vincristine—hematologic cancer	6.67e-05	0.000263	CcSEcCtD
Thioridazine—Oedema peripheral—Epirubicin—hematologic cancer	6.67e-05	0.000263	CcSEcCtD
Thioridazine—Headache—Vincristine—hematologic cancer	6.64e-05	0.000262	CcSEcCtD
Thioridazine—Hypotension—Betamethasone—hematologic cancer	6.6e-05	0.00026	CcSEcCtD
Thioridazine—Hypotension—Dexamethasone—hematologic cancer	6.6e-05	0.00026	CcSEcCtD
Thioridazine—Nausea—Carmustine—hematologic cancer	6.59e-05	0.00026	CcSEcCtD
Thioridazine—Vomiting—Irinotecan—hematologic cancer	6.56e-05	0.000259	CcSEcCtD
Thioridazine—Vomiting—Mitoxantrone—hematologic cancer	6.56e-05	0.000259	CcSEcCtD
Thioridazine—Nausea—Alitretinoin—hematologic cancer	6.53e-05	0.000258	CcSEcCtD
Thioridazine—Agranulocytosis—Doxorubicin—hematologic cancer	6.51e-05	0.000257	CcSEcCtD
Thioridazine—Rash—Mitoxantrone—hematologic cancer	6.51e-05	0.000257	CcSEcCtD
Thioridazine—Rash—Irinotecan—hematologic cancer	6.51e-05	0.000257	CcSEcCtD
Thioridazine—Dermatitis—Mitoxantrone—hematologic cancer	6.5e-05	0.000256	CcSEcCtD
Thioridazine—Dermatitis—Irinotecan—hematologic cancer	6.5e-05	0.000256	CcSEcCtD
Thioridazine—Headache—Irinotecan—hematologic cancer	6.46e-05	0.000255	CcSEcCtD
Thioridazine—Headache—Mitoxantrone—hematologic cancer	6.46e-05	0.000255	CcSEcCtD
Thioridazine—Nausea—Ifosfamide—hematologic cancer	6.45e-05	0.000255	CcSEcCtD
Thioridazine—Feeling abnormal—Triamcinolone—hematologic cancer	6.41e-05	0.000253	CcSEcCtD
Thioridazine—Diarrhoea—Cisplatin—hematologic cancer	6.41e-05	0.000253	CcSEcCtD
Thioridazine—Vomiting—Gemcitabine—hematologic cancer	6.39e-05	0.000252	CcSEcCtD
Thioridazine—Mental disorder—Methotrexate—hematologic cancer	6.34e-05	0.00025	CcSEcCtD
Thioridazine—Rash—Gemcitabine—hematologic cancer	6.34e-05	0.00025	CcSEcCtD
Thioridazine—Dermatitis—Gemcitabine—hematologic cancer	6.33e-05	0.00025	CcSEcCtD
Thioridazine—Hypersensitivity—Etoposide—hematologic cancer	6.32e-05	0.000249	CcSEcCtD
Thioridazine—Erythema—Methotrexate—hematologic cancer	6.3e-05	0.000248	CcSEcCtD
Thioridazine—Headache—Gemcitabine—hematologic cancer	6.3e-05	0.000248	CcSEcCtD
Thioridazine—Nausea—Vincristine—hematologic cancer	6.29e-05	0.000248	CcSEcCtD
Thioridazine—Hypersensitivity—Prednisolone—hematologic cancer	6.24e-05	0.000246	CcSEcCtD
Thioridazine—Oedema peripheral—Doxorubicin—hematologic cancer	6.17e-05	0.000243	CcSEcCtD
Thioridazine—Body temperature increased—Triamcinolone—hematologic cancer	6.15e-05	0.000243	CcSEcCtD
Thioridazine—Oedema—Prednisone—hematologic cancer	6.15e-05	0.000243	CcSEcCtD
Thioridazine—Decreased appetite—Betamethasone—hematologic cancer	6.14e-05	0.000242	CcSEcCtD
Thioridazine—Decreased appetite—Dexamethasone—hematologic cancer	6.14e-05	0.000242	CcSEcCtD
Thioridazine—Nausea—Mitoxantrone—hematologic cancer	6.13e-05	0.000242	CcSEcCtD
Thioridazine—Nausea—Irinotecan—hematologic cancer	6.13e-05	0.000242	CcSEcCtD
Thioridazine—Arrhythmia—Epirubicin—hematologic cancer	6.05e-05	0.000239	CcSEcCtD
Thioridazine—Tachycardia—Prednisone—hematologic cancer	6e-05	0.000237	CcSEcCtD
Thioridazine—Nausea—Gemcitabine—hematologic cancer	5.97e-05	0.000235	CcSEcCtD
Thioridazine—Vomiting—Cisplatin—hematologic cancer	5.96e-05	0.000235	CcSEcCtD
Thioridazine—Hyperhidrosis—Prednisone—hematologic cancer	5.95e-05	0.000234	CcSEcCtD
Thioridazine—Vision blurred—Methotrexate—hematologic cancer	5.94e-05	0.000234	CcSEcCtD
Thioridazine—Mental disorder—Epirubicin—hematologic cancer	5.93e-05	0.000234	CcSEcCtD
Thioridazine—Rash—Cisplatin—hematologic cancer	5.91e-05	0.000233	CcSEcCtD
Thioridazine—Dermatitis—Cisplatin—hematologic cancer	5.9e-05	0.000233	CcSEcCtD
Thioridazine—Erythema—Epirubicin—hematologic cancer	5.89e-05	0.000232	CcSEcCtD
Thioridazine—Diarrhoea—Etoposide—hematologic cancer	5.87e-05	0.000232	CcSEcCtD
Thioridazine—Anorexia—Prednisone—hematologic cancer	5.86e-05	0.000231	CcSEcCtD
Thioridazine—Anaemia—Methotrexate—hematologic cancer	5.82e-05	0.00023	CcSEcCtD
Thioridazine—Feeling abnormal—Betamethasone—hematologic cancer	5.82e-05	0.00023	CcSEcCtD
Thioridazine—Feeling abnormal—Dexamethasone—hematologic cancer	5.82e-05	0.00023	CcSEcCtD
Thioridazine—Fluphenazine—ABCB1—hematologic cancer	5.74e-05	0.0283	CrCbGaD
Thioridazine—Hypersensitivity—Triamcinolone—hematologic cancer	5.74e-05	0.000226	CcSEcCtD
Thioridazine—Leukopenia—Methotrexate—hematologic cancer	5.64e-05	0.000222	CcSEcCtD
Thioridazine—Arrhythmia—Doxorubicin—hematologic cancer	5.6e-05	0.000221	CcSEcCtD
Thioridazine—Body temperature increased—Betamethasone—hematologic cancer	5.58e-05	0.00022	CcSEcCtD
Thioridazine—Body temperature increased—Dexamethasone—hematologic cancer	5.58e-05	0.00022	CcSEcCtD
Thioridazine—Nausea—Cisplatin—hematologic cancer	5.56e-05	0.000219	CcSEcCtD
Thioridazine—Vision blurred—Epirubicin—hematologic cancer	5.56e-05	0.000219	CcSEcCtD
Thioridazine—Clomipramine—ALB—hematologic cancer	5.5e-05	0.0271	CrCbGaD
Thioridazine—Mental disorder—Doxorubicin—hematologic cancer	5.49e-05	0.000216	CcSEcCtD
Thioridazine—Vomiting—Etoposide—hematologic cancer	5.46e-05	0.000215	CcSEcCtD
Thioridazine—Erythema—Doxorubicin—hematologic cancer	5.45e-05	0.000215	CcSEcCtD
Thioridazine—Anaemia—Epirubicin—hematologic cancer	5.45e-05	0.000215	CcSEcCtD
Thioridazine—Agitation—Epirubicin—hematologic cancer	5.42e-05	0.000214	CcSEcCtD
Thioridazine—Rash—Etoposide—hematologic cancer	5.41e-05	0.000213	CcSEcCtD
Thioridazine—Dermatitis—Etoposide—hematologic cancer	5.41e-05	0.000213	CcSEcCtD
Thioridazine—Headache—Etoposide—hematologic cancer	5.38e-05	0.000212	CcSEcCtD
Thioridazine—Decreased appetite—Prednisone—hematologic cancer	5.35e-05	0.000211	CcSEcCtD
Thioridazine—Rash—Prednisolone—hematologic cancer	5.34e-05	0.00021	CcSEcCtD
Thioridazine—Dermatitis—Prednisolone—hematologic cancer	5.33e-05	0.00021	CcSEcCtD
Thioridazine—Headache—Prednisolone—hematologic cancer	5.3e-05	0.000209	CcSEcCtD
Thioridazine—Leukopenia—Epirubicin—hematologic cancer	5.28e-05	0.000208	CcSEcCtD
Thioridazine—Constipation—Prednisone—hematologic cancer	5.26e-05	0.000207	CcSEcCtD
Thioridazine—Clomipramine—ABCB1—hematologic cancer	5.25e-05	0.0258	CrCbGaD
Thioridazine—Confusional state—Methotrexate—hematologic cancer	5.18e-05	0.000204	CcSEcCtD
Thioridazine—Vision blurred—Doxorubicin—hematologic cancer	5.14e-05	0.000203	CcSEcCtD
Thioridazine—Nausea—Etoposide—hematologic cancer	5.1e-05	0.000201	CcSEcCtD
Thioridazine—Feeling abnormal—Prednisone—hematologic cancer	5.07e-05	0.0002	CcSEcCtD
Thioridazine—Anaemia—Doxorubicin—hematologic cancer	5.04e-05	0.000199	CcSEcCtD
Thioridazine—Thrombocytopenia—Methotrexate—hematologic cancer	5.03e-05	0.000198	CcSEcCtD
Thioridazine—Nausea—Prednisolone—hematologic cancer	5.03e-05	0.000198	CcSEcCtD
Thioridazine—Agitation—Doxorubicin—hematologic cancer	5.01e-05	0.000198	CcSEcCtD
Thioridazine—Hyperhidrosis—Methotrexate—hematologic cancer	4.97e-05	0.000196	CcSEcCtD
Thioridazine—Vomiting—Triamcinolone—hematologic cancer	4.95e-05	0.000195	CcSEcCtD
Thioridazine—Rash—Triamcinolone—hematologic cancer	4.91e-05	0.000194	CcSEcCtD
Thioridazine—Dermatitis—Triamcinolone—hematologic cancer	4.9e-05	0.000193	CcSEcCtD
Thioridazine—Anorexia—Methotrexate—hematologic cancer	4.9e-05	0.000193	CcSEcCtD
Thioridazine—Leukopenia—Doxorubicin—hematologic cancer	4.88e-05	0.000193	CcSEcCtD
Thioridazine—Headache—Triamcinolone—hematologic cancer	4.88e-05	0.000192	CcSEcCtD
Thioridazine—Body temperature increased—Prednisone—hematologic cancer	4.86e-05	0.000192	CcSEcCtD
Thioridazine—Confusional state—Epirubicin—hematologic cancer	4.85e-05	0.000191	CcSEcCtD
Thioridazine—Diarrhoea—Betamethasone—hematologic cancer	4.83e-05	0.000191	CcSEcCtD
Thioridazine—Diarrhoea—Dexamethasone—hematologic cancer	4.83e-05	0.000191	CcSEcCtD
Thioridazine—Oedema—Epirubicin—hematologic cancer	4.81e-05	0.00019	CcSEcCtD
Thioridazine—Hypotension—Methotrexate—hematologic cancer	4.8e-05	0.000189	CcSEcCtD
Thioridazine—Thrombocytopenia—Epirubicin—hematologic cancer	4.71e-05	0.000186	CcSEcCtD
Thioridazine—Tachycardia—Epirubicin—hematologic cancer	4.7e-05	0.000185	CcSEcCtD
Thioridazine—Hyperhidrosis—Epirubicin—hematologic cancer	4.65e-05	0.000183	CcSEcCtD
Thioridazine—Promethazine—ABCB1—hematologic cancer	4.65e-05	0.0229	CrCbGaD
Thioridazine—Nausea—Triamcinolone—hematologic cancer	4.62e-05	0.000182	CcSEcCtD
Thioridazine—Trifluoperazine—ABCB1—hematologic cancer	4.59e-05	0.0226	CrCbGaD
Thioridazine—Anorexia—Epirubicin—hematologic cancer	4.59e-05	0.000181	CcSEcCtD
Thioridazine—Somnolence—Methotrexate—hematologic cancer	4.57e-05	0.00018	CcSEcCtD
Thioridazine—Hypersensitivity—Prednisone—hematologic cancer	4.53e-05	0.000179	CcSEcCtD
Thioridazine—Hypotension—Epirubicin—hematologic cancer	4.5e-05	0.000177	CcSEcCtD
Thioridazine—Vomiting—Betamethasone—hematologic cancer	4.49e-05	0.000177	CcSEcCtD
Thioridazine—Vomiting—Dexamethasone—hematologic cancer	4.49e-05	0.000177	CcSEcCtD
Thioridazine—Confusional state—Doxorubicin—hematologic cancer	4.49e-05	0.000177	CcSEcCtD
Thioridazine—Decreased appetite—Methotrexate—hematologic cancer	4.47e-05	0.000176	CcSEcCtD
Thioridazine—Rash—Dexamethasone—hematologic cancer	4.45e-05	0.000176	CcSEcCtD
Thioridazine—Rash—Betamethasone—hematologic cancer	4.45e-05	0.000176	CcSEcCtD
Thioridazine—Oedema—Doxorubicin—hematologic cancer	4.45e-05	0.000176	CcSEcCtD
Thioridazine—Dermatitis—Betamethasone—hematologic cancer	4.45e-05	0.000175	CcSEcCtD
Thioridazine—Dermatitis—Dexamethasone—hematologic cancer	4.45e-05	0.000175	CcSEcCtD
Thioridazine—Headache—Dexamethasone—hematologic cancer	4.42e-05	0.000174	CcSEcCtD
Thioridazine—Headache—Betamethasone—hematologic cancer	4.42e-05	0.000174	CcSEcCtD
Thioridazine—Thrombocytopenia—Doxorubicin—hematologic cancer	4.36e-05	0.000172	CcSEcCtD
Thioridazine—Tachycardia—Doxorubicin—hematologic cancer	4.34e-05	0.000171	CcSEcCtD
Thioridazine—Hyperhidrosis—Doxorubicin—hematologic cancer	4.3e-05	0.00017	CcSEcCtD
Thioridazine—Somnolence—Epirubicin—hematologic cancer	4.28e-05	0.000169	CcSEcCtD
Thioridazine—Anorexia—Doxorubicin—hematologic cancer	4.24e-05	0.000167	CcSEcCtD
Thioridazine—Feeling abnormal—Methotrexate—hematologic cancer	4.24e-05	0.000167	CcSEcCtD
Thioridazine—Diarrhoea—Prednisone—hematologic cancer	4.21e-05	0.000166	CcSEcCtD
Thioridazine—Nausea—Betamethasone—hematologic cancer	4.2e-05	0.000165	CcSEcCtD
Thioridazine—Nausea—Dexamethasone—hematologic cancer	4.2e-05	0.000165	CcSEcCtD
Thioridazine—Decreased appetite—Epirubicin—hematologic cancer	4.18e-05	0.000165	CcSEcCtD
Thioridazine—Hypotension—Doxorubicin—hematologic cancer	4.16e-05	0.000164	CcSEcCtD
Thioridazine—Constipation—Epirubicin—hematologic cancer	4.11e-05	0.000162	CcSEcCtD
Thioridazine—Body temperature increased—Methotrexate—hematologic cancer	4.06e-05	0.00016	CcSEcCtD
Thioridazine—Feeling abnormal—Epirubicin—hematologic cancer	3.96e-05	0.000156	CcSEcCtD
Thioridazine—Somnolence—Doxorubicin—hematologic cancer	3.96e-05	0.000156	CcSEcCtD
Thioridazine—Vomiting—Prednisone—hematologic cancer	3.91e-05	0.000154	CcSEcCtD
Thioridazine—Rash—Prednisone—hematologic cancer	3.88e-05	0.000153	CcSEcCtD
Thioridazine—Dermatitis—Prednisone—hematologic cancer	3.87e-05	0.000153	CcSEcCtD
Thioridazine—Decreased appetite—Doxorubicin—hematologic cancer	3.87e-05	0.000153	CcSEcCtD
Thioridazine—Headache—Prednisone—hematologic cancer	3.85e-05	0.000152	CcSEcCtD
Thioridazine—Constipation—Doxorubicin—hematologic cancer	3.81e-05	0.00015	CcSEcCtD
Thioridazine—Body temperature increased—Epirubicin—hematologic cancer	3.8e-05	0.00015	CcSEcCtD
Thioridazine—Hypersensitivity—Methotrexate—hematologic cancer	3.79e-05	0.000149	CcSEcCtD
Thioridazine—Chlorpromazine—ALB—hematologic cancer	3.77e-05	0.0186	CrCbGaD
Thioridazine—Feeling abnormal—Doxorubicin—hematologic cancer	3.67e-05	0.000145	CcSEcCtD
Thioridazine—Nausea—Prednisone—hematologic cancer	3.65e-05	0.000144	CcSEcCtD
Thioridazine—Chlorpromazine—ABCB1—hematologic cancer	3.6e-05	0.0177	CrCbGaD
Thioridazine—Hypersensitivity—Epirubicin—hematologic cancer	3.54e-05	0.00014	CcSEcCtD
Thioridazine—Body temperature increased—Doxorubicin—hematologic cancer	3.52e-05	0.000139	CcSEcCtD
Thioridazine—Diarrhoea—Methotrexate—hematologic cancer	3.52e-05	0.000139	CcSEcCtD
Thioridazine—Diarrhoea—Epirubicin—hematologic cancer	3.29e-05	0.00013	CcSEcCtD
Thioridazine—Hypersensitivity—Doxorubicin—hematologic cancer	3.28e-05	0.000129	CcSEcCtD
Thioridazine—Vomiting—Methotrexate—hematologic cancer	3.27e-05	0.000129	CcSEcCtD
Thioridazine—Rash—Methotrexate—hematologic cancer	3.24e-05	0.000128	CcSEcCtD
Thioridazine—Dermatitis—Methotrexate—hematologic cancer	3.24e-05	0.000128	CcSEcCtD
Thioridazine—Headache—Methotrexate—hematologic cancer	3.22e-05	0.000127	CcSEcCtD
Thioridazine—Vomiting—Epirubicin—hematologic cancer	3.06e-05	0.000121	CcSEcCtD
Thioridazine—Nausea—Methotrexate—hematologic cancer	3.05e-05	0.00012	CcSEcCtD
Thioridazine—Diarrhoea—Doxorubicin—hematologic cancer	3.05e-05	0.00012	CcSEcCtD
Thioridazine—Rash—Epirubicin—hematologic cancer	3.03e-05	0.00012	CcSEcCtD
Thioridazine—Dermatitis—Epirubicin—hematologic cancer	3.03e-05	0.000119	CcSEcCtD
Thioridazine—Headache—Epirubicin—hematologic cancer	3.01e-05	0.000119	CcSEcCtD
Thioridazine—Nausea—Epirubicin—hematologic cancer	2.86e-05	0.000113	CcSEcCtD
Thioridazine—Vomiting—Doxorubicin—hematologic cancer	2.83e-05	0.000112	CcSEcCtD
Thioridazine—Rash—Doxorubicin—hematologic cancer	2.81e-05	0.000111	CcSEcCtD
Thioridazine—Dermatitis—Doxorubicin—hematologic cancer	2.8e-05	0.000111	CcSEcCtD
Thioridazine—Headache—Doxorubicin—hematologic cancer	2.79e-05	0.00011	CcSEcCtD
Thioridazine—Nausea—Doxorubicin—hematologic cancer	2.64e-05	0.000104	CcSEcCtD
Thioridazine—HTR1A—Signaling Pathways—SRC—hematologic cancer	2.56e-06	2.19e-05	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—AKT1—hematologic cancer	2.56e-06	2.18e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.56e-06	2.18e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—SRC—hematologic cancer	2.55e-06	2.18e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—TP53—hematologic cancer	2.55e-06	2.17e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	2.55e-06	2.17e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—TP53—hematologic cancer	2.55e-06	2.17e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CASP3—hematologic cancer	2.54e-06	2.17e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	2.54e-06	2.17e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL2—hematologic cancer	2.54e-06	2.17e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CASP3—hematologic cancer	2.54e-06	2.16e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.54e-06	2.16e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL2—hematologic cancer	2.53e-06	2.16e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—IL6—hematologic cancer	2.53e-06	2.15e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—IL6—hematologic cancer	2.52e-06	2.15e-05	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	2.52e-06	2.15e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CCND1—hematologic cancer	2.51e-06	2.14e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	2.51e-06	2.14e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	2.51e-06	2.14e-05	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	2.51e-06	2.14e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EP300—hematologic cancer	2.51e-06	2.14e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—JUN—hematologic cancer	2.51e-06	2.14e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—VEGFA—hematologic cancer	2.5e-06	2.13e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CASP3—hematologic cancer	2.5e-06	2.13e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL2—hematologic cancer	2.49e-06	2.13e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	2.49e-06	2.12e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	2.49e-06	2.12e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—VEGFA—hematologic cancer	2.48e-06	2.12e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—IL6—hematologic cancer	2.48e-06	2.12e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—EP300—hematologic cancer	2.48e-06	2.11e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CCND1—hematologic cancer	2.47e-06	2.11e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	2.47e-06	2.11e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—STAT3—hematologic cancer	2.47e-06	2.11e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—JUN—hematologic cancer	2.47e-06	2.11e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CCND1—hematologic cancer	2.47e-06	2.11e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—KRAS—hematologic cancer	2.47e-06	2.11e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—NRAS—hematologic cancer	2.47e-06	2.1e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—JUN—hematologic cancer	2.46e-06	2.1e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—STAT3—hematologic cancer	2.46e-06	2.1e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—NRAS—hematologic cancer	2.45e-06	2.09e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.44e-06	2.08e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—SRC—hematologic cancer	2.44e-06	2.08e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HRAS—hematologic cancer	2.44e-06	2.08e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HRAS—hematologic cancer	2.43e-06	2.08e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CDKN1A—hematologic cancer	2.43e-06	2.08e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CCND1—hematologic cancer	2.43e-06	2.07e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PTEN—hematologic cancer	2.43e-06	2.07e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—JUN—hematologic cancer	2.42e-06	2.07e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	2.42e-06	2.07e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	2.42e-06	2.06e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—ALB—hematologic cancer	2.41e-06	2.06e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	2.4e-06	2.05e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CDKN1A—hematologic cancer	2.39e-06	2.04e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CDKN1A—hematologic cancer	2.39e-06	2.04e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PTEN—hematologic cancer	2.39e-06	2.04e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.39e-06	2.04e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PTEN—hematologic cancer	2.39e-06	2.04e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PTEN—hematologic cancer	2.38e-06	2.03e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	2.38e-06	2.03e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK8—hematologic cancer	2.37e-06	2.03e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.37e-06	2.02e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—AKT1—hematologic cancer	2.37e-06	2.02e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MAPK3—hematologic cancer	2.36e-06	2.01e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	2.36e-06	2.01e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	2.35e-06	2.01e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.35e-06	2e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	2.35e-06	2e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MAPK3—hematologic cancer	2.35e-06	2e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	2.35e-06	2e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PTEN—hematologic cancer	2.35e-06	2e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	2.34e-06	2e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	2.34e-06	1.99e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK8—hematologic cancer	2.34e-06	1.99e-05	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	2.33e-06	1.99e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—IL6—hematologic cancer	2.33e-06	1.99e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK8—hematologic cancer	2.33e-06	1.99e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—IL6—hematologic cancer	2.33e-06	1.99e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—AKT1—hematologic cancer	2.33e-06	1.99e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—AKT1—hematologic cancer	2.33e-06	1.98e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EP300—hematologic cancer	2.31e-06	1.97e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	2.31e-06	1.97e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	2.31e-06	1.97e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.31e-06	1.97e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	2.3e-06	1.96e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—MYC—hematologic cancer	2.3e-06	1.96e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	2.29e-06	1.96e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TGFB1—hematologic cancer	2.29e-06	1.95e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	2.29e-06	1.95e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	2.29e-06	1.95e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—MYC—hematologic cancer	2.29e-06	1.95e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	2.28e-06	1.95e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TGFB1—hematologic cancer	2.28e-06	1.94e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EP300—hematologic cancer	2.28e-06	1.94e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—EP300—hematologic cancer	2.28e-06	1.94e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EP300—hematologic cancer	2.27e-06	1.94e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.27e-06	1.94e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—PIK3CA—hematologic cancer	2.27e-06	1.93e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	2.25e-06	1.92e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—SRC—hematologic cancer	2.25e-06	1.92e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	2.25e-06	1.92e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.25e-06	1.92e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	2.25e-06	1.92e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EP300—hematologic cancer	2.24e-06	1.91e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	2.23e-06	1.9e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.23e-06	1.9e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—ALB—hematologic cancer	2.22e-06	1.89e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—SRC—hematologic cancer	2.21e-06	1.89e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—SRC—hematologic cancer	2.21e-06	1.89e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—ALB—hematologic cancer	2.2e-06	1.88e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—TP53—hematologic cancer	2.19e-06	1.87e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—VEGFA—hematologic cancer	2.19e-06	1.87e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	2.19e-06	1.87e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	2.18e-06	1.86e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	2.18e-06	1.86e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—SRC—hematologic cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—STAT3—hematologic cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—NRAS—hematologic cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—VEGFA—hematologic cancer	2.16e-06	1.84e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—VEGFA—hematologic cancer	2.15e-06	1.84e-05	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—AKT1—hematologic cancer	2.15e-06	1.84e-05	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—AKT1—hematologic cancer	2.15e-06	1.83e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—STAT3—hematologic cancer	2.14e-06	1.82e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—STAT3—hematologic cancer	2.13e-06	1.82e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—NRAS—hematologic cancer	2.13e-06	1.82e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.13e-06	1.82e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—NRAS—hematologic cancer	2.13e-06	1.81e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	2.13e-06	1.81e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.12e-06	1.81e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—KRAS—hematologic cancer	2.12e-06	1.81e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	2.12e-06	1.81e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	2.12e-06	1.81e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	2.11e-06	1.8e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—KRAS—hematologic cancer	2.11e-06	1.8e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.1e-06	1.8e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HRAS—hematologic cancer	2.1e-06	1.79e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—STAT3—hematologic cancer	2.1e-06	1.79e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—NRAS—hematologic cancer	2.09e-06	1.78e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	2.09e-06	1.78e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	2.09e-06	1.78e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MAPK3—hematologic cancer	2.07e-06	1.77e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	2.07e-06	1.77e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PTEN—hematologic cancer	2.06e-06	1.76e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MAPK3—hematologic cancer	2.04e-06	1.74e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MAPK3—hematologic cancer	2.04e-06	1.74e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	2.02e-06	1.72e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—MYC—hematologic cancer	2.02e-06	1.72e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	2.02e-06	1.72e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TGFB1—hematologic cancer	2.01e-06	1.72e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.01e-06	1.71e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—IL6—hematologic cancer	2.01e-06	1.71e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	2e-06	1.71e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	2e-06	1.7e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—MYC—hematologic cancer	1.98e-06	1.69e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—MYC—hematologic cancer	1.98e-06	1.69e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TGFB1—hematologic cancer	1.98e-06	1.69e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TGFB1—hematologic cancer	1.98e-06	1.69e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—EP300—hematologic cancer	1.97e-06	1.68e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.96e-06	1.67e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.96e-06	1.67e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—PIK3CA—hematologic cancer	1.95e-06	1.66e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—MYC—hematologic cancer	1.95e-06	1.66e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	1.94e-06	1.66e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.94e-06	1.66e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.94e-06	1.66e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.94e-06	1.66e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—PIK3CA—hematologic cancer	1.94e-06	1.65e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.94e-06	1.65e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.94e-06	1.65e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.9e-06	1.62e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—TP53—hematologic cancer	1.89e-06	1.61e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—ALB—hematologic cancer	1.88e-06	1.6e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—TP53—hematologic cancer	1.88e-06	1.6e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—KRAS—hematologic cancer	1.86e-06	1.59e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	1.86e-06	1.58e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.86e-06	1.58e-05	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—AKT1—hematologic cancer	1.85e-06	1.58e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.84e-06	1.57e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—KRAS—hematologic cancer	1.83e-06	1.56e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1.83e-06	1.56e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—KRAS—hematologic cancer	1.83e-06	1.56e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	1.81e-06	1.54e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HRAS—hematologic cancer	1.8e-06	1.54e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	1.8e-06	1.54e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—KRAS—hematologic cancer	1.8e-06	1.54e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.8e-06	1.53e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	1.8e-06	1.53e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	1.8e-06	1.53e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HRAS—hematologic cancer	1.8e-06	1.53e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—EP300—hematologic cancer	1.76e-06	1.5e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—IL6—hematologic cancer	1.73e-06	1.47e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	1.72e-06	1.47e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—IL6—hematologic cancer	1.72e-06	1.47e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—PIK3CA—hematologic cancer	1.71e-06	1.46e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.69e-06	1.44e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—PIK3CA—hematologic cancer	1.68e-06	1.44e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.68e-06	1.44e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—PIK3CA—hematologic cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.68e-06	1.43e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	1.67e-06	1.42e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.66e-06	1.42e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—TP53—hematologic cancer	1.66e-06	1.41e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	1.65e-06	1.41e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	1.65e-06	1.41e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	1.64e-06	1.4e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—TP53—hematologic cancer	1.63e-06	1.39e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—TP53—hematologic cancer	1.63e-06	1.39e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—EP300—hematologic cancer	1.61e-06	1.38e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—EP300—hematologic cancer	1.6e-06	1.37e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—TP53—hematologic cancer	1.6e-06	1.37e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	1.6e-06	1.36e-05	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—AKT1—hematologic cancer	1.59e-06	1.36e-05	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—AKT1—hematologic cancer	1.59e-06	1.35e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HRAS—hematologic cancer	1.58e-06	1.35e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—HRAS—hematologic cancer	1.56e-06	1.33e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HRAS—hematologic cancer	1.56e-06	1.33e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	1.53e-06	1.31e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HRAS—hematologic cancer	1.53e-06	1.31e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	1.53e-06	1.3e-05	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	1.52e-06	1.29e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—IL6—hematologic cancer	1.52e-06	1.29e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—AKT1—hematologic cancer	1.5e-06	1.28e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—IL6—hematologic cancer	1.49e-06	1.27e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—IL6—hematologic cancer	1.49e-06	1.27e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	1.48e-06	1.26e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—IL6—hematologic cancer	1.46e-06	1.25e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	1.46e-06	1.25e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.46e-06	1.24e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.43e-06	1.22e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	1.42e-06	1.21e-05	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—AKT1—hematologic cancer	1.4e-06	1.19e-05	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—AKT1—hematologic cancer	1.38e-06	1.17e-05	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.38e-06	1.17e-05	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—AKT1—hematologic cancer	1.37e-06	1.17e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—EP300—hematologic cancer	1.37e-06	1.17e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	1.36e-06	1.16e-05	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—AKT1—hematologic cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	1.35e-06	1.15e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.3e-06	1.11e-05	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	1.25e-06	1.07e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.19e-06	1.02e-05	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—AKT1—hematologic cancer	1.19e-06	1.01e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.18e-06	1.01e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.06e-06	9.05e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.01e-06	8.63e-06	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—AKT1—hematologic cancer	9.76e-07	8.32e-06	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—AKT1—hematologic cancer	9.67e-07	8.25e-06	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—AKT1—hematologic cancer	8.27e-07	7.05e-06	CbGpPWpGaD
